Many men with low levels could be spared from invasive procedures and frequent testing ...

For prostate cancer patients with low-volume tumors and metastasis, the median overall survival was 37.13 months. Prostate cancer patients with metastatic disease and low-volume primary tumors appear ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

Please provide your email address to receive an email when new articles are posted on . An AI model showed tumor size to be an independent risk factor for prostate cancer metastasis and recurrence. AI ...

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health significantly impacts overall well-being, making ...

Numerous men write off early symptoms of Prostate Cancer as part of the aging process. Recognizing these signs and seeking ...